BCM
ICCM icon

Bourgeon Capital Management’s IceCure Medical ICCM Stock Holding History

Bourgeon Capital Management’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-90
Closed -$3K – 426
2022
Q3 		$3K Hold
90
– – ﹤0.01% 290
2022
Q2 		$5K Hold
90
– – ﹤0.01% 249
2022
Q1 		$6K Buy
+90
New +$6.98K ﹤0.01% 248

Other funds holding ICCM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bourgeon Capital Management's ICCM Position: Q4 2022 in Review

Bourgeon Capital Management sold out of IceCure Medical (ICCM) in Q4 2022, closing a stake of 90 shares — an estimated $3K sold.

Bourgeon Capital Management first reported a position in ICCM in Q1 2022 and held it in 3 quarters. The position peaked at $6K in Q1 2022. 10 funds tracked by Wall St. Rank hold ICCM as of Q4 2022.

  • Bourgeon Capital Management reported no remaining IceCure Medical position as of Q4 2022 after selling out during the quarter.
  • Bourgeon Capital Management sold 90 IceCure Medical shares in Q4 2022, an estimated $3K.
  • Bourgeon Capital Management first reported a position in IceCure Medical in Q1 2022 and held it in 3 quarters.
  • Bourgeon Capital Management's IceCure Medical position peaked at $6K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held IceCure Medical as of Q4 2022.

Based on Bourgeon Capital Management's 13F filing for Q4 2022, filed 20 Jan 2023.